Tengteng Yu

Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001).

Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 27, 2026

Biphenotypic NK-Large granular lymphocytic leukemia with aggressive clinical features: a case report and literature review.

Biphenotypic NK-Large granular lymphocytic leukemia with aggressive clinical features: a case report and literature review.

Journal: Annals of hematology

Published: May 24, 2025

Identification of a CAR-Derived Clone by NGS-Based MRD After Fully Human BCMA CAR T-Cell Therapy in Multiple Myeloma.

Identification of a CAR-Derived Clone by NGS-Based MRD After Fully Human BCMA CAR T-Cell Therapy in Multiple Myeloma.

Journal: American journal of hematology

Published: April 24, 2025

Improving predictive accuracy in multiple myeloma using a plasma cell profile derived from single-cell RNA sequencing.

Improving predictive accuracy in multiple myeloma using a plasma cell profile derived from single-cell RNA sequencing.

Journal: Haematologica

Published: February 17, 2025

The specific transcriptional profile and clonal selection of monoclonal gammopathy of undetermined significancelike behavior predict an exceptionally favorable prognosis in multiple myeloma.

The specific transcriptional profile and clonal selection of monoclonal gammopathy of undetermined significancelike behavior predict an exceptionally favorable prognosis in multiple myeloma.

Journal: Haematologica

Published: February 06, 2025

Uncommon biphasic CAR-T expansion induces hemophagocytic lymphohistiocytosis-like syndrome and fatal multiple infections following BCMA CAR-T cell therapy: a case report.

Uncommon biphasic CAR-T expansion induces hemophagocytic lymphohistiocytosis-like syndrome and fatal multiple infections following BCMA CAR-T cell therapy: a case report.

Journal: Journal for immunotherapy of cancer

Published: November 08, 2024

Zanubrutinib plus Ixazomib and Dexamethasone in Newly Diagnosed Symptomatic Waldenström Macroglobulinemia: A Phase II Study.

Zanubrutinib plus Ixazomib and Dexamethasone in Newly Diagnosed Symptomatic Waldenström Macroglobulinemia: A Phase II Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 28, 2024

Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia: a multicenter phase II study.

Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia: a multicenter phase II study.

Journal: Signal transduction and targeted therapy

Published: August 28, 2024

Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma.

Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma.

Journal: Leukemia

Published: May 26, 2024

Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing.

Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 21, 2024

Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma.

Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma.

Journal: Leukemia

Published: November 13, 2023

Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM).

Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM).

Journal: Annals of hematology

Published: October 12, 2023

Showing 1-12 of 24

Last Updated: 09/26/2026